ALS Recent Progress Evaluation at MDA 2023.

Published Date: 01 Mar 2023

In the MDA session track on amyotrophic lateral sclerosis, Stanley Appel, MD, provided his perspective on the condition, the most recent scientific developments that will benefit patients, and the direction that research and treatment in the area are taking.

Read Full News

Latest News

TBI History Tied to False-Negative Alzheimer’s Blood Test

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

p-Tau217 May Predict Cognitive Decline Years Before Symptoms

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

ENTF Stim Boosts Freedom From Disability Post-Stroke

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab Noninferior to Ocrelizumab in Relapsing MS

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

FDA Neurology Roundup: June 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI Uncovers ‘Invisible’ Cortical Lesions in MS MRI Scans

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Todays Updates

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup

A recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.

FDA Approves New ROS1 Inhibitor for NSCLC

The newly approved inhibitor is for patients who previously received another drug of the same class.

Latest News

FDA-approved p-tau217/amyloid-beta-42 testing missed more amyloid PET-positive cases among older adults with prior TBI, a cross-sectional cohort study shows.

Higher plasma p-tau217 levels identified cognitively sound older adults at greater risk for future cognitive impairment up to a decade before symptom onset.

Electromagnetic stimulation combined with physical and occupational therapy is linked to a higher rate of freedom from disability post-stroke than sham, a study shows.

Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

AI-enhanced analysis of conventional MRI scans reveals thousands of hidden cortical lesions in multiple sclerosis, potentially opening a new window into disease progression.

News All Time

RFK Jr. Seeks to Peek at Americans' Medical Records for Clues on Autism and Vaccines

Some public health leaders have raised doubts that giving access would be legal or even useful

MAHA's Autism Treatments: Camel's Milk, Stem Cell Injections, and Spelling Therapy

Experts say some of the methods may be fraudulent

Primitive Reflexes May Predict Dementia

Two or more frontal release signs in cognitively normal people tied to higher risk of dementia

Brain Institute Halts Research; Parkinson's Deaths Fall; Meet the 'Dementia Rebels'

News and commentary from the world of neurology and neuroscience

Alzheimer's May Be Worse for People Taking Popular Supplement

Glucosamine tied to faster progression in people with established neurodegeneration

Genetic Risk of Autism, ADHD Decreased as Diagnoses Increased

Study offers "new perspective for ongoing debates" about increasing diagnoses, researchers say

Report: Law Firms Cheated in Filing Claims With NFL's Concussion Settlement Fund

The fund was meant to last for 65 years

Ebola's Brain Effects Persist More Than 7 Years After Infection

Many survivors still had neurologic symptoms, most notably memory loss

Alzheimer's and Psilocybin; Migraine and Driving; What New MS Criteria Reveal

News and commentary from the world of neurology and neuroscience

Hospital's Brain Tumor Cluster; Princess's Lung Transplant; Plastic Surgery Deaths

Health news and commentary gathered by MedPage Today staff

Brain Disorders and TBI May Fuel Each Other

Two-way relationships with traumatic brain injury emerge in a large study of veterans

FDA Reverses Course on Neuro Drugs; Omega-3s and Dementia; Brain Death Test Lawsuit

News and commentary from the world of neurology and neuroscience

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Genetic screening in the wake of new therapies will identify more at-risk relatives

First State Bans Paraquat, a Weed Killer Linked to Parkinson's Disease

The herbicide is used widely in the U.S. but banned in China and Europe

Study Suggests No Link Between Prenatal Tylenol and Risks for Autism, ADHD

Research shows the power of negative control analyses

NFL Star Diagnosed With ALS at 39; 'No Surprises' Windfall; Arizona Plague Scare

Health news and commentary gathered by MedPage Today staff

Recommended News For You

When a Groundbreaking Cancer Therapy Causes Cancer.

Non-small cell lung cancer patients who are ineligible for platinum-based chemotherapy benefit from atezolizumab monotherapy.

Use of social media during pregnancy may increase depression.

A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.

Study reveals increase in late-stage breast cancer diagnoses in US

A smartphone app enhances the tracking of recovery following breast and gynecologic oncology surgery, according to JAMA.

After two years, a significant left nasal obstruction was finally diagnosed.

Recommended Articles For You

Survivorship Planning Beyond Active Cancer Care 

Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key 

Prevention of Thrombotic Complications in High-Risk Patients 

The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

2.

Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?

3.

FDA approves Blenrep for relapsed or refractory multiple myeloma

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

1.

The importance of understanding normal serum osmolality

2.

Innovative Approaches in Oncology for Modern Medicine

3.

Macrocytic Anemia: A Comprehensive Review of Pathophysiology, Diagnosis, and Clinical Management

4.

The Future of Hematology: Innovations Every Doctor Should Know

5.

Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part III

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

5.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot